These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4538675)

  • 1. [B type of Willebrand-Jürgens syndrome. A family study].
    Meskó K; Kovács E; Kolumbusz L; Méhes K
    Orv Hetil; 1972 Oct; 113(43):2571-8. PubMed ID: 4538675
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies of a large family with von Willebrand-Jürgens syndrome].
    Walther C
    Z Gesamte Inn Med; 1967 May; 22(9):268-71. PubMed ID: 5301933
    [No Abstract]   [Full Text] [Related]  

  • 3. [Investigation into a family with factor XI deficiency and Willebrand-Jürgens syndrome].
    Plendl H; Grote W
    Med Welt; 1979 Aug; 30(34):1244-8. PubMed ID: 315024
    [No Abstract]   [Full Text] [Related]  

  • 4. [Family study of the Willebrand-Jurgens syndrome type B].
    Schott G
    Z Gesamte Inn Med; 1971 Sep; 26(17):566-9. PubMed ID: 5315975
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent investigations of the first bleeder family in Aland (Finland) described by von Willebrand.
    Nyman D; Eriksson AW; Blombäck M; Frants RR; Wahlberg P
    Thromb Haemost; 1981 Feb; 45(1):73-6. PubMed ID: 6972630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Willebrand-Jurgens disease. Report of 2 cases].
    Mancini AF
    Minerva Pediatr; 1971 Oct; 23(42):1765-73. PubMed ID: 5316204
    [No Abstract]   [Full Text] [Related]  

  • 7. [Von Willebrand's syndrome in a consanguineous family].
    Lasierra Cirujeda J; Barrao Comps F
    Rev Clin Esp; 1969 Apr; 113(1):55-8. PubMed ID: 5307358
    [No Abstract]   [Full Text] [Related]  

  • 8. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD.
    Eikenboom J; Van Marion V; Putter H; Goodeve A; Rodeghiero F; Castaman G; Federici AB; Batlle J; Meyer D; Mazurier C; Goudemand J; Schneppenheim R; Budde U; Ingerslev J; Vorlova Z; Habart D; Holmberg L; Lethagen S; Pasi J; Hill F; Peake I
    J Thromb Haemost; 2006 Apr; 4(4):774-82. PubMed ID: 16634746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of von Willebrand's disease and factor IX deficiency in males and females of a family].
    Liñares Ruiz MS; Rodríguez Fernández JM
    Sangre (Barc); 1983; 28(6):782-91. PubMed ID: 6608799
    [No Abstract]   [Full Text] [Related]  

  • 10. Type 2N von Willebrand disease mutations in Brazilian individuals.
    Simon D; Roisenberg I
    Haemophilia; 2004 Sep; 10(5):473-6. PubMed ID: 15357773
    [No Abstract]   [Full Text] [Related]  

  • 11. [Genetic forms of von Willebrand's disease].
    Pniejnia Olszyński W
    Acta Haematol Pol; 1982; 13(3-4):91-102. PubMed ID: 6985184
    [No Abstract]   [Full Text] [Related]  

  • 12. Variants of von Willebrand's disease. Analysis of 55 cases.
    Chen Z; Wang ZY; Chen SR; Wang DF; Zhang YM; Wang HL
    Chin Med J (Engl); 1984 Mar; 97(3):151-4. PubMed ID: 6432476
    [No Abstract]   [Full Text] [Related]  

  • 13. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD).
    Tosetto A; Rodeghiero F; Castaman G; Goodeve A; Federici AB; Batlle J; Meyer D; Fressinaud E; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Budde U; Ingerslev J; Vorlova Z; Habart D; Holmberg L; Lethagen S; Pasi J; Hill F; Peake I
    J Thromb Haemost; 2006 Apr; 4(4):766-73. PubMed ID: 16634745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Von Willebrand's disease, with special reference to laboratory diagnosis (the ristomycin test)].
    Boda Z; Rák K
    Orv Hetil; 1980 Oct; 121(42):2563-7. PubMed ID: 6258126
    [No Abstract]   [Full Text] [Related]  

  • 15. Arg578Gln mutations in the von Willebrand factor gene in three unrelated cases of type IIB von Willebrand disease.
    Piao YC; Lavergne JM; Boyer-Neumann C; Schandelong A; Alessi MC; Meyer D
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):787-9. PubMed ID: 8292729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian type 1 VWD study.
    James PD; Paterson AD; Notley C; Cameron C; Hegadorn C; Tinlin S; Brown C; O'Brien L; Leggo J; Lillicrap D;
    J Thromb Haemost; 2006 Apr; 4(4):783-92. PubMed ID: 16634747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on four hereditary blood disorders in Iceland.
    Jensson O
    Acta Med Scand Suppl; 1978; 618():1-28. PubMed ID: 308294
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined hereditary disorders of haemophilia B Leyden (-6 G-->A) and type 1 von Willebrand disease.
    Pernod G; Vinciguerra C; Gaucher C; Mazurier C; Polack B; Négrier C
    Thromb Haemost; 1996 Aug; 76(2):151-5. PubMed ID: 8865521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The life long haemorrhagic disorders with prolonged bleeding time and associated factor VIII deficiency (von Willebrand's disease).
    Dube B; Somani PN; Vaish SK; Udapa KN; Gupta SP
    J Assoc Physicians India; 1972 Dec; 20(12):929-33. PubMed ID: 4540604
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand disease: an international, multicenter study.
    Castaman G; Rodeghiero F; Tosetto A; Cappelletti A; Baudo F; Eikenboom JC; Federici AB; Lethagen S; Linari S; Lusher J; Nishino M; Petrini P; Srivastava A; Ungerstedt JS
    J Thromb Haemost; 2006 Oct; 4(10):2164-9. PubMed ID: 16999850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.